News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,303 Results
Type
Article (39848)
Company Profile (202)
Press Release (661253)
Section
Business (209186)
Career Advice (1923)
Deals (35003)
Drug Delivery (102)
Drug Development (79291)
Employer Resources (148)
FDA (15829)
Job Trends (15264)
News (347190)
Policy (32759)
Tag
Academia (2715)
Alliances (46076)
Alzheimer's disease (1344)
Approvals (15777)
Artificial intelligence (180)
Bankruptcy (323)
Best Places to Work (12291)
Biotechnology (145)
Breast cancer (219)
Cancer (1626)
Cardiovascular disease (139)
Career advice (1551)
CAR-T (116)
Cell therapy (347)
Clinical research (63648)
Collaboration (613)
Compensation (318)
COVID-19 (2358)
C-suite (147)
Data (1509)
Diabetes (202)
Diagnostics (6632)
Earnings (94068)
Employer resources (121)
Events (122078)
Executive appointments (510)
FDA (16644)
Funding (543)
Gene therapy (238)
GLP-1 (688)
Government (4755)
Healthcare (20531)
Infectious disease (2466)
Inflammatory bowel disease (128)
Interviews (322)
IPO (16947)
Job creations (3409)
Job search strategy (1371)
Layoffs (464)
Legal (7652)
Lung cancer (241)
Manufacturing (240)
Medical device (14233)
Medtech (14238)
Mergers & acquisitions (18380)
Metabolic disorders (544)
Neuroscience (1735)
NextGen: Class of 2025 (7080)
Non-profit (5009)
Northern California (1920)
Obesity (312)
Opinion (203)
Patents (142)
People (55929)
Phase I (19868)
Phase II (28204)
Phase III (21164)
Pipeline (633)
Postmarket research (2193)
Preclinical (8313)
Radiopharmaceuticals (259)
Rare diseases (310)
Real estate (5710)
Regulatory (21998)
Research institute (2432)
Resumes & cover letters (339)
Southern California (1665)
Startups (3316)
United States (17292)
Vaccines (581)
Weight loss (231)
Date
Today (149)
Last 7 days (446)
Last 30 days (2120)
Last 365 days (36927)
2025 (1887)
2024 (37327)
2023 (42383)
2022 (53016)
2021 (57342)
2020 (56699)
2019 (50587)
2018 (37411)
2017 (33678)
2016 (33120)
2015 (38525)
2014 (31629)
2013 (26798)
2012 (28035)
2011 (28758)
2010 (25653)
Location
Africa (725)
Arizona (166)
Asia (41698)
Australia (6825)
California (4329)
Canada (1578)
China (379)
Colorado (198)
Connecticut (220)
Europe (93046)
Florida (620)
Georgia (155)
Illinois (446)
Indiana (255)
Maryland (734)
Massachusetts (3440)
Michigan (201)
Minnesota (334)
New Jersey (1222)
New York (1228)
North Carolina (882)
Northern California (1920)
Ohio (163)
Pennsylvania (1014)
South America (1123)
Southern California (1665)
Texas (634)
Utah (127)
Washington State (444)
701,303 Results for "20 20 bioresponse".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight Loss
‘Bulls Disappointed’ as Amgen’s MariTide Demonstrates 20% Weight Loss
With Amgen’s MariTide results at the lower end of investors’ expectation of 20% to 25% weight loss, the much-anticipated readout sent the company’s shares tumbling.
November 26, 2024
·
2 min read
·
Annalee Armstrong
Business
Seaport, With 20/20 Hindsight, Takes Lessons From Neuropsych’s Stumbles
Amidst a “renaissance” of interest in neuropsychiatry, Seaport’s executive team is taking nothing for granted.
January 15, 2025
·
5 min read
·
Annalee Armstrong
Multiple sclerosis
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis
New research has found that MS patients treated with anti-CD20 antibodies, such as Roche’s Ocrevus, do not experience significantly slower progression of disability.
September 26, 2024
·
2 min read
·
Tristan Manalac
Press Releases
FDA Roundup: December 20, 2024
December 23, 2024
·
7 min read
Press Releases
Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
January 10, 2025
·
6 min read
Press Releases
DNA Sequencing Market Size to Hit USD 106.20 Billion by 2034
January 7, 2025
·
1 min read
Press Releases
Psyence Biomed Announces $2.0 Million Private Placement
December 23, 2024
·
6 min read
Press Releases
Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
November 27, 2024
·
3 min read
Press Releases
Advanced Bifurcation Systems Inc. Secures $20.8 Million in Financing and Expands Board of Directors
January 17, 2025
·
2 min read
Press Releases
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
January 10, 2025
·
1 min read
1 of 70,131
Next
